Welcome to the digital.law repository at the University of Washington

Infringement of Swiss-Type Second Medical Use Patent Claims in Germany – Recent Developments in Case Law

Show simple item record

dc.contributor.author Zigann, Matthias
dc.date.accessioned 2017-10-31T14:47:06Z
dc.date.available 2017-10-31T14:47:06Z
dc.date.issued 2017-10
dc.identifier.citation 12 WASH. J.L. TECH.& ARTS 245 (2017) en_US
dc.identifier.issn 2157-2534
dc.identifier.uri http://hdl.handle.net/1773.1/1737
dc.description Washington Journal of Law, Technology & Arts, Volume 12 , Issue 3, Symposium 2017 en_US
dc.description.abstract Following recent regional court decisions on the infringement of second medical use patent claims, the German concept of manifest arrangement—previously believed to provide a safe harbor for generic pharmaceutical companies as long as they skinny-labeled their products—may be subject to a new interpretation. The German decisions are part of a Europe wide series of decisions on the same or similar subject matter and prove to be patent owner friendly. en_US
dc.language.iso en_US en_US
dc.publisher Seattle: Washington Journal of Law, Technology & Arts, University of Washington School of Law en_US
dc.subject Intellectual Property en_US
dc.subject Future of Innovation in Medicine Conference en_US
dc.title Infringement of Swiss-Type Second Medical Use Patent Claims in Germany – Recent Developments in Case Law en_US
dc.type Article en_US
dc.rights.holder Copyright Matthias Zigann 2017 en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search digital.law


Advanced Search

Browse

My Account